SCHEMBL11620858

SCHEMBL11620858

CCCCCC(c1ccc(-c2ccc(Cl)cc2)cc1)N1CCNCC1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.53
▸ CYP2D6 P10635 2/20 0.50
▸ CYP19A1 P11511 1/20 0.50
▸ SLC6A4 P31645 11/20 0.46
▸ SLC6A2 P23975 9/20 0.46
▸ OPRM1 P35372 3/20 0.44
▸ OPRD1 P41143 3/20 0.44
▸ SLC6A3 Q01959 5/20 0.43
▸ OPRK1 P41145 2/20 0.43
▸ OPRL1 P41146 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ GLA P06280 1/20 0.43
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11625461 0.96 HRH3 (0.58) HRH3CYP2D6CYP19A1SLC6A4SLC6A2
SCHEMBL11627158 0.91 CYP2D6 (0.54) HRH3CYP2D6CYP19A1SLC6A4SLC6A2
SCHEMBL11623491 0.85 CYP2D6 (0.57) CYP2D6CYP19A1SLC6A4SLC6A2OPRM1
SCHEMBL11625094 0.80 HRH3 (0.51) HRH3CYP2D6OPRM1OPRD1OPRK1
SCHEMBL11623365 0.78 HRH3 (0.49) HRH3CYP2D6SLC6A4SLC6A2OPRM1
SCHEMBL13974437 0.78 HRH3 (0.51) HRH3CYP2D6SLC6A4SLC6A2OPRM1
SCHEMBL10900699 0.77 OPRD1 (0.53) HRH3SLC6A4SLC6A2OPRM1OPRD1
SCHEMBL2256683 0.76 SLC6A4 (0.56) SLC6A4SLC6A2OPRM1OPRD1SLC6A3
SCHEMBL11626541 0.76 HRH3 (0.53) HRH3OPRM1OPRD1OPRK1OPRL1
SCHEMBL11624816 0.76 HRH3 (0.55) HRH3CYP2D6OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4125612-A N-1-(p-Biphenylalkyl)piperazines and their use as anti-inflammatory agents SCHERING CORPORATION (US) 1978-11-14 — — US disclosed
Send feedback